Therapie der Lungenembolie

Deutsche Medizinische Wochenschrift

Volumn 121, Issue 19, 1996, Pages 629-634

  Zahn, R ^a   Lotter, R ^a   Seidl, K ^a   Senges, J ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

CLINICAL TRIAL; DRUG EFFICACY; EMERGENCY MEDICINE; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; SHORT SURVEY;

HUMANS; PULMONARY EMBOLISM;

EID: 0029929120     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1023965     Document Type: Article

References (38)

1. Albada, J., H. K. Nieuwenhuis, J. J. Sixma: Treatment of acute venous thromboembolism with low molecular weight heparin (fragmin). Results of a double-blind randomized study. Circulation 80 (1989), 935-940.
2. Alpert, J. S., R. Smith, J. Carlson, I. S. Ockene, L Dexter, J. E. Dalen: Mortality in patients treated for pulmonary embolism. J. Amer. med. Ass. 236 (1976), 1477-1480.
3. Barritt, D. W., S. C. Jordan: Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1960/I, 1309-1312.
4. Chakko, S., F. Richards: Right sided cardiac thrombi and pulmonary embolism. Amer. J. Cardiol. 59 (1987), 195-196.
5. Clarke, D. B., L. D. Abrams: Pulmonary embolectomy. A 25 year experience. J. thorac. cardiovasc. Surg. 92 (1986), 442-445.
6. Dalla-Volta, S., A. Palla, A. Santolicandro, C. Giuntini, V. Pengo, O. Visioli, P. Zonzin, D. Zanuttini, F. Barbaresi, G. Agnelli, M. Morpurgo, M. G. Marini, L. Visani: PAIMS II: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J. Amer. Coll. Cardiol. 20 (1992), 520-526.
7. Farfel, Z., M. Schechter, Z. Vered, S. Rath, D. Goor, J. Gafni: Review of echocardiographically diagnosed right heart entrapment of pulmonary emboli-in-transit with emphasis on management. Amer. Heart J. 113 (1987), 171-178.
8. Goldhaber, S. Z., C. M. Kessler, J. A. Heit, J. Markis, G. V. R. K. Sharma, D. Dawley, J. S. Nagel, M. Meyerovitz, D. Kim, D. E. Vaughan, S. S. Tumeh, D. Drum, J. Loscalzo, K. Reagan, A. P. Selwyn, J. Anderson, E. Braunwald: A randomized controlled trial of recombinant tissue-type plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet 1988/11, 293-298.
9. Goldhaber, S. Z., C. M. Kessler, J. A. Heit, C. G. Elliott, W. R. Friedenberg, D. E. Heiselman, D. B. Wilson, J. A. Parker, D. Bennett, M. L. Feldstein, A. P. Selwyn, D. Kim, G. V. R. K. Sharma, J. S. Nagel, M. F. Meyerovitz: Recombinant tissue-type plasminogen activator versus a novel dosing regime of urokinase in acute pulmonary embolism. A randomized controlled multicenter trial. J. Amer. Coll. Cardiol. 20 (1992), 24-30.
10. Goldhaber, S. Z., W. H. Haire, M. L. Feldstein, M. Miller, R. Toltzis, J. L. Smith, A. M. T. Da Silva, P. C. Come, R. T. Lee, J. A. Parker, A. Mogtader, T. J. McDonough, E. Braunwald: Alteplase versus heparin in acute pulmonary embolism. Randomized trial assessing right-ventricular function and pulmonary perfusion. Lancet 341 (1993), 507-511.
11. Goldhaber, S. Z., M. L. Feldstein, H. Sors: Two trials of reduced bolus alteplase in the treatment of pulmonary embolism. Chest 106 (1994), 725-726.
12. Gray, H. H., J. M. Morgan, M. Paneth, G. A. H. Miller: Pulmonary embolectomy for acute massive pulmonary embolism. An analysis of 71 cases. Brit. Heart J. 60 (1988), 196-200.
13. Grosser, K. D.: Akute Lungenembolie. Behandlung nach Schweregraden. Dtsch. Ärztebl. 85 (1988), B-587-B-594.
14. Gulba, D. C., C. Schmid, H. G. Borst, P. Lichtlen, R. Dietz, F. C. Luft: Medical compared with surgical treatment for massive pulmonary embolism. Lancet 343 (1994), 576-577.
15. Hopf, H. B., T. Floßdorf, M. Breulmann: Rekombinanter Gewebeplasminogenaktivator (rt-PA) zur Thrombolyse lebensbedrohlicher Lungenembolien in der perioperativen Phase. Intensivmed. 29 (1992), 281-287.
16. Horstkotte, D., M. P. Heintzen, B. E. Strauer: Kombinierte mechanische und thrombolytische Wiedereröffnung der Lungenstrombahn bei massiver Lungenarterienembolie mit kardiogenem Schock. Intensivmed. 27 (1990), 124-132.
17. Iversen, S., U. Hake, E. Gerharz, Y. Kutschera, N. Wittlich, H. Jakob, W. Schmied, H. Oelert: Pulmonale Thrombendarteriektomie bei thromboembolischer pulmonaler Hypertonie. Dtsch. med. Wschr. 117 (1992), 1087-1092.
18. Karwinski, B., E. Svedsen: Comparison of clinical and postmortem diagnosis of pulmonary embolism. J. clin. Pathol. 42 (1989), 135.
19. Kienast, J., G. Silling-Engelhardt: Thrombolysetherapie der Lungenembolie. Internist (Berl.) 33 (1992), 216-224.
20. Kronik, G. für die European Working Group on Echocardiography: The European Cooperative Study on the clinical significance of right heart thrombi. Europ. Heart J. 10 (1989), 1046-1059.
21. Levine, M., J. Hirsh, J. Weitz, M. Cruikshank, J. Neemeh, A. G. Turpie, M. Gent: A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest 98 (1990), 1473-1479.
22. Ly, B., H. Arnesen, H. Eie, R. Hol: A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta med. scand. 203 (1978), 465-470.
23. Matthias, K.: Interventionelle Kathetertherapie bei Lungenembolie. Intensivmed. 29 (1992), 61-65.
24. Meissner, E., J. Niedermeyer, H. Fabel: Akute Lungenembolie. Z. Kardiol. 82 (1993), Suppl. 2, 3-12.
25. Meyer, G., H. Sors, B. Charbonnier, W. Kasper, J. P. Bassand, I. H. Kerr, E. Lesaffre, P. Vanhove, M. Verstraete on behalf of The European Cooperative Study Group For Pulmonary Embolism: Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism. A European multicentre double-blind trial. J. Amer. Coll. Cardiol. 19 (1992), 239-245.
26. Moser, K. M., W. R. Auger, P. F. Feduller: Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 81 (1990), 1735-1743.
27. Theis, W.: Thrombolysetherapie tiefer Beinvenenthrombosen. Internist 33 (1992), 225-231.
28. Research Committee of the British Thoracic Society: Optimum duration of anticoagulation for deep-venous thrombosis and pulmonary embolism. Lancet 340 (1992), 873-876.
29. Romaniuk, P., T. Thieme, C. Miersch, C. Stobbe, F. Stößlein: Zur Implantation von Vena-cava-Filtern bei akuten Lungenembolien. Z. Kardiol. 82, Suppl. 2 (1993), 35-40.
30. Scholz, K. H., T. Hilmer, S. Schuster, J. Wijcik, H. Kreuzer, U. Tebbe: Thrombolyse bei reanimierten Patienten mit Lungenembolie. Dtsch. med. Wschr. 115 (1990), 930-935.
31. Schulman, S., A. S. Rhedin, P. Lindmarker, A. Carlsson, G. Lärfas, P. Nicol, E. Loogna, E. Svensson, B. Ljundberg, H. Walter, S. Viering, S. Nordlander, B. Leijd, K. A. Jönson, M. Hjorth, O. Linder, J. Boberg, and the Duration of Anticoagulation Trial Study Group: A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New Engl. J. Med. 332 (1995), 1661-1665.
32. Theis, W.: Thrombolysetherapie tiefer Beinvenenthrombosen. Internist (Berl.) 33 (1992), 225-231.
33. Théry, C., G. Simmoneau, G. Meyer, O. Heleneon, F. Bridey, C. Armagnac, P. d'Azemar, J. P. Coquart: Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (Fraxiparine) compared with intravenous unfractioned heparin in the curative treatment of submassive pulmonary embolism. A dose ranging study. Circulation 85 (1992), 1380-1389.
34. Théry, C., P. Assman, N. Amrouni, J. Becquart, P. Pruvost, M. Lesenne, R. Legghe, P. Marache: Use of a new removable vena cava filter in order to prevent pulmonary embolism in patients submitted to thrombolysis. Europ. Heart J. 11 (1990), 334-341.
35. Tibbut, A., J. A. Davies, J. A. Anderson, E. W. L. Fletcher, J. Hamill: Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism. Brit. med. J. 1974/1, 343-347.
36. Urokinase Pulmonary Embolism Trial, Phase I. J. Amer. med. Ass. 214 (1970), 1606-1613.
37. The USPET investigators: Urokinase-streptokinase embolism trial. Phase 2 results. J. Amer. med. Ass. 229 (1974), 1606-1613.
38. Verstraete, M., G. A. H. Miller, H. Bounameaux, B. Charbonnier, J. P. Colle, G. Lecorf, G. A. Marbert, P. Mombaerts, C. G. Olsson: Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation 77 (1988), 353-360.